Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Autor: Coombes RC; Department of Surgery and Cancer, Imperial College London, London, UK. c.coombes@imperial.ac.uk., Badman PD; Department of Surgery and Cancer, Imperial College London, London, UK., Lozano-Kuehne JP; Department of Surgery and Cancer, Imperial College London, London, UK., Liu X; Department of Surgery and Cancer, Imperial College London, London, UK., Macpherson IR; Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK., Zubairi I; Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK., Baird RD; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK., Rosenfeld N; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK., Garcia-Corbacho J; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK., Cresti N; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Plummer R; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Armstrong A; Breast Research Office, The Christie NHS Foundation Trust, Christie Hospital, Manchester, UK., Allerton R; C8 Admin Offices, Russell's Hall Hospital, Russells Hall, UK., Landers D; Astrazeneca, Cheshire, UK., Nicholas H; Department of Surgery and Cancer, Imperial College London, London, UK., McLellan L; ECMC Programme Office, Research and Innovation, Cancer Research UK, London, UK., Lim A; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Mouliere F; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Pardo OE; Department of Surgery and Cancer, Imperial College London, London, UK., Ferguson V; Department of Surgery and Cancer, Imperial College London, London, UK., Seckl MJ; Department of Surgery and Cancer, Imperial College London, London, UK. m.seckl@imperial.ac.uk.
Jazyk: angličtina
Zdroj: Nature communications [Nat Commun] 2023 Jan 17; Vol. 14 (1), pp. 260. Date of Electronic Publication: 2023 Jan 17.
DOI: 10.1038/s41467-023-35969-4
Databáze: MEDLINE